Global Gene Therapy for Inherited Genetic Disorders Supply, Demand and Key Producers, 2023-2029
Page: 98
Published Date: 19 Jan 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
This report studies the global Gene Therapy for Inherited Genetic Disorders demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy for Inherited Genetic Disorders, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy for Inherited Genetic Disorders that contribute to its increasing demand across many markets.
The global Gene Therapy for Inherited Genetic Disorders market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.
Highlights and key features of the study
Global Gene Therapy for Inherited Genetic Disorders total market, 2018-2029, (USD Million)
Global Gene Therapy for Inherited Genetic Disorders total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Therapy for Inherited Genetic Disorders total market, key domestic companies and share, (USD Million)
Global Gene Therapy for Inherited Genetic Disorders revenue by player and market share 2018-2023, (USD Million)
Global Gene Therapy for Inherited Genetic Disorders total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene Therapy for Inherited Genetic Disorders total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Therapy for Inherited Genetic Disorders market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, Orchard Therapeutics Plc and Spark Therapeutics Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy for Inherited Genetic Disorders market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy for Inherited Genetic Disorders Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Gene Therapy for Inherited Genetic Disorders Market, Segmentation by Type
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Global Gene Therapy for Inherited Genetic Disorders Market, Segmentation by Application
Hospital
Clinic
Research Institute
Others
Companies Profiled:
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
Key Questions Answered
1. How big is the global Gene Therapy for Inherited Genetic Disorders market?
2. What is the demand of the global Gene Therapy for Inherited Genetic Disorders market?
3. What is the year over year growth of the global Gene Therapy for Inherited Genetic Disorders market?
4. What is the total value of the global Gene Therapy for Inherited Genetic Disorders market?
5. Who are the major players in the global Gene Therapy for Inherited Genetic Disorders market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Gene Therapy for Inherited Genetic Disorders Introduction
1.2 World Gene Therapy for Inherited Genetic Disorders Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Therapy for Inherited Genetic Disorders Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy for Inherited Genetic Disorders Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.3.3 China Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.3.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.3.5 Japan Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.3.6 South Korea Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.3.7 ASEAN Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.3.8 India Gene Therapy for Inherited Genetic Disorders Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy for Inherited Genetic Disorders Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy for Inherited Genetic Disorders Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.2 World Gene Therapy for Inherited Genetic Disorders Consumption Value by Region
2.2.1 World Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2018-2023)
2.2.2 World Gene Therapy for Inherited Genetic Disorders Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.4 China Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.5 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.6 Japan Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.7 South Korea Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.8 ASEAN Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
2.9 India Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029)
3.1 World Gene Therapy for Inherited Genetic Disorders Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy for Inherited Genetic Disorders Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy for Inherited Genetic Disorders in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy for Inherited Genetic Disorders in 2022
3.3 Gene Therapy for Inherited Genetic Disorders Company Evaluation Quadrant
3.4 Gene Therapy for Inherited Genetic Disorders Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy for Inherited Genetic Disorders Market: Region Footprint
3.4.2 Gene Therapy for Inherited Genetic Disorders Market: Company Product Type Footprint
3.4.3 Gene Therapy for Inherited Genetic Disorders Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: Gene Therapy for Inherited Genetic Disorders Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy for Inherited Genetic Disorders Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy for Inherited Genetic Disorders Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Therapy for Inherited Genetic Disorders Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy for Inherited Genetic Disorders Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Therapy for Inherited Genetic Disorders Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Therapy for Inherited Genetic Disorders Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy for Inherited Genetic Disorders Revenue, (2018-2023)
4.4 China Based Companies Gene Therapy for Inherited Genetic Disorders Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Therapy for Inherited Genetic Disorders Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy for Inherited Genetic Disorders Revenue, (2018-2023)
4.5 Rest of World Based Gene Therapy for Inherited Genetic Disorders Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Therapy for Inherited Genetic Disorders Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Therapy for Inherited Genetic Disorders Revenue, (2018-2023)
5.1 World Gene Therapy for Inherited Genetic Disorders Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Eye Disorders
5.2.2 Hematological Disorders
5.2.3 Central Nervous System Disorders
5.2.4 Muscular Disorders
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023)
5.3.2 World Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029)
5.3.3 World Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2018-2029)
6.1 World Gene Therapy for Inherited Genetic Disorders Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Research Institute
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023)
6.3.2 World Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029)
6.3.3 World Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2029)
7.1 BioMarin Pharmaceutical Inc.
7.1.1 BioMarin Pharmaceutical Inc. Details
7.1.2 BioMarin Pharmaceutical Inc. Major Business
7.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
7.1.4 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BioMarin Pharmaceutical Inc. Recent Developments/Updates
7.1.6 BioMarin Pharmaceutical Inc. Competitive Strengths & Weaknesses
7.2 bluebird bio Inc.
7.2.1 bluebird bio Inc. Details
7.2.2 bluebird bio Inc. Major Business
7.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
7.2.4 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 bluebird bio Inc. Recent Developments/Updates
7.2.6 bluebird bio Inc. Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Services
7.3.4 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Orchard Therapeutics Plc
7.4.1 Orchard Therapeutics Plc Details
7.4.2 Orchard Therapeutics Plc Major Business
7.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Services
7.4.4 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Orchard Therapeutics Plc Recent Developments/Updates
7.4.6 Orchard Therapeutics Plc Competitive Strengths & Weaknesses
7.5 Spark Therapeutics Inc.
7.5.1 Spark Therapeutics Inc. Details
7.5.2 Spark Therapeutics Inc. Major Business
7.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
7.5.4 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Spark Therapeutics Inc. Recent Developments/Updates
7.5.6 Spark Therapeutics Inc. Competitive Strengths & Weaknesses
8.1 Gene Therapy for Inherited Genetic Disorders Industry Chain
8.2 Gene Therapy for Inherited Genetic Disorders Upstream Analysis
8.3 Gene Therapy for Inherited Genetic Disorders Midstream Analysis
8.4 Gene Therapy for Inherited Genetic Disorders Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Gene Therapy for Inherited Genetic Disorders Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy for Inherited Genetic Disorders Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy for Inherited Genetic Disorders Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy for Inherited Genetic Disorders Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Therapy for Inherited Genetic Disorders Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Therapy for Inherited Genetic Disorders Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy for Inherited Genetic Disorders Players in 2022
Table 12. World Gene Therapy for Inherited Genetic Disorders Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Therapy for Inherited Genetic Disorders Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy for Inherited Genetic Disorders Player
Table 15. Gene Therapy for Inherited Genetic Disorders Market: Company Product Type Footprint
Table 16. Gene Therapy for Inherited Genetic Disorders Market: Company Product Application Footprint
Table 17. Gene Therapy for Inherited Genetic Disorders Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy for Inherited Genetic Disorders Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Therapy for Inherited Genetic Disorders Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Therapy for Inherited Genetic Disorders Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy for Inherited Genetic Disorders Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Therapy for Inherited Genetic Disorders Revenue Market Share (2018-2023)
Table 23. China Based Gene Therapy for Inherited Genetic Disorders Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy for Inherited Genetic Disorders Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Therapy for Inherited Genetic Disorders Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Therapy for Inherited Genetic Disorders Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Therapy for Inherited Genetic Disorders Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy for Inherited Genetic Disorders Revenue Market Share (2018-2023)
Table 29. World Gene Therapy for Inherited Genetic Disorders Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Therapy for Inherited Genetic Disorders Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene Therapy for Inherited Genetic Disorders Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene Therapy for Inherited Genetic Disorders Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Therapy for Inherited Genetic Disorders Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Therapy for Inherited Genetic Disorders Market Size by Application (2024-2029) & (USD Million)
Table 35. BioMarin Pharmaceutical Inc. Basic Information, Area Served and Competitors
Table 36. BioMarin Pharmaceutical Inc. Major Business
Table 37. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
Table 38. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BioMarin Pharmaceutical Inc. Recent Developments/Updates
Table 40. BioMarin Pharmaceutical Inc. Competitive Strengths & Weaknesses
Table 41. bluebird bio Inc. Basic Information, Area Served and Competitors
Table 42. bluebird bio Inc. Major Business
Table 43. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
Table 44. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. bluebird bio Inc. Recent Developments/Updates
Table 46. bluebird bio Inc. Competitive Strengths & Weaknesses
Table 47. Novartis AG Basic Information, Area Served and Competitors
Table 48. Novartis AG Major Business
Table 49. Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Services
Table 50. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis AG Recent Developments/Updates
Table 52. Novartis AG Competitive Strengths & Weaknesses
Table 53. Orchard Therapeutics Plc Basic Information, Area Served and Competitors
Table 54. Orchard Therapeutics Plc Major Business
Table 55. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Services
Table 56. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Orchard Therapeutics Plc Recent Developments/Updates
Table 58. Spark Therapeutics Inc. Basic Information, Area Served and Competitors
Table 59. Spark Therapeutics Inc. Major Business
Table 60. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
Table 61. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Gene Therapy for Inherited Genetic Disorders Upstream (Raw Materials)
Table 63. Gene Therapy for Inherited Genetic Disorders Typical Customers
List of Figure
Figure 1. Gene Therapy for Inherited Genetic Disorders Picture
Figure 2. World Gene Therapy for Inherited Genetic Disorders Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy for Inherited Genetic Disorders Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Therapy for Inherited Genetic Disorders Revenue (2018-2029) & (USD Million)
Figure 13. Gene Therapy for Inherited Genetic Disorders Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy for Inherited Genetic Disorders by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy for Inherited Genetic Disorders Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy for Inherited Genetic Disorders Markets in 2022
Figure 27. United States VS China: Gene Therapy for Inherited Genetic Disorders Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Therapy for Inherited Genetic Disorders Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type in 2022
Figure 31. Eye Disorders
Figure 32. Hematological Disorders
Figure 33. Central Nervous System Disorders
Figure 34. Muscular Disorders
Figure 35. Others
Figure 36. World Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2018-2029)
Figure 37. World Gene Therapy for Inherited Genetic Disorders Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Clinic
Figure 41. Research Institute
Figure 42. Others
Figure 43. Gene Therapy for Inherited Genetic Disorders Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
BioMarin Pharmaceutical Inc. bluebird bio Inc. Novartis AG Orchard Therapeutics Plc Spark Therapeutics Inc.
Related Reports
11 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
